Add this result to my export selection Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C - guidance (MTG27) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 23 September 2015 Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C Read Summary Type: Guidance (Add filter)
Add this result to my export selection EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing - guidance (MTG12) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 09 January 2013 Evidence-based recommendations on EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing Read Summary Type: Guidance (Add filter)
Add this result to my export selection Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura - guidance (TA667) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 16 December 2020 Evidence-based recommendations on caplacizumab (Cablivi) with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic Read Summary Type: Guidance (Add filter) Type: Medicines Current Awareness (Add filter)
Add this result to my export selection Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma - guidance (TA666) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 16 December 2020 Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin) for treating advanced or unresectable hepatocellular carcinoma in adults Read Summary Type: Guidance (Add filter) Type: Medicines Current Awareness (Add filter)
Add this result to my export selection Depression in adults with a chronic physical health problem: recognition and management : guidance (CG91) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 28 October 2009 This guideline covers identifying, treating and managing depression in people aged 18 and over who also have a chronic physical health problem such as cancer, heart disease or diabetes. It aims to... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal) - guidance (TA647) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 02 September 2020 NICE is unable to make a recommendation about the use in the NHS of eculizumab (Soliris) for treating relapsing neuromyelitis optica because Alexion Pharma UK Read Summary Type: Guidance (Add filter)
Add this result to my export selection Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal) - guidance (TA646) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 02 September 2020 NICE is unable to make a recommendation on glasdegib with chemotherapy for untreated acute myeloid leukaemia because Pfizer did not provide an evidence Read Summary Type: Guidance (Add filter)
Add this result to my export selection Avelumab with axitinib for untreated advanced renal cell carcinoma - guidance (TA645) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 02 September 2020 Evidence-based recommendations on avelumab (Bavencio) with axitinib (Inlyta) for untreated advanced renal cell carcinoma in adults Read Summary Type: Guidance (Add filter)
Add this result to my export selection Perioperative care in adults : guidance (NG180) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 19 August 2020 This guideline covers care for adults (aged 18 and over) having elective or emergency surgery, including dental surgery. It covers all phases of perioperative care, from the time people are booked... Read Summary Type: Guidance (Add filter)
Add this result to my export selection moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment - guidance (MTG2) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 25 March 2011 Evidence-based recommendations on moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment Read Summary Type: Guidance (Add filter)